SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease From Oscient Pharmaceuticals Corporation And EPIX Pharmaceuticals, Inc.